Man N, Wang QL, Li HH, Adu-Frimpong M, Sun CY, Zhang KY, et al
But, on the other hand, the induction of senescence during cancer treatment could be used as a potential mechanism to induce immune reaction against cancer cells
Heppner KM, Kirigiti M, Secher A, Paulsen SJ, Buckingham R, Pyke C, et al
Is there a KLOW peptide dosage and frequency chart
Professor Muresanus research contributions include: Principal investigator for the CARS trial (Cerebrolysin and Recovery After Stroke), the largest randomized controlled trial examining functional outcomes Lead investigator for CAPTAIN trials evaluating Cerebrolysin in traumatic brain injury populations Extensive research on neurotrophic factor signaling and neuroprotective mechanisms Development of multimodal therapeutic strategies combining Cerebrolysin with rehabilitation Investigations of dose-response relationships and optimal treatment protocols across neurological conditions His work has been instrumental in advancing understanding of peptidergic neuroprotection, though clinical translation challenges remain a focus of ongoing investigation
[DOI] [PubMed] [Google Scholar] 43.Djakovic Z., Djakovic I., Cesarec V., Madzarac G., Becejac T., Zukanovic G., Drmic D., Batelja L., Sever A.Z., Kolenc D., et al
